Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis [1]

Journal of the American Academy of Dermatology

Volumn 49, Issue 1, 2003, Pages 157-158

  Wang, Linda C ^a   Medenica, Maria M ^a   Shea, Christopher R ^a   Busbey, Shail ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; INFLIXIMAB; RUTOSIDE;

ADULT; CASE REPORT; CROHN DISEASE; DISEASE CLASSIFICATION; DRUG RECHALLENGE; DRUG WITHDRAWAL; ECZEMA; ECZEMATID LIKE PURPURA OF DOUCAS AND KAPETENAKIS; EXTRAVASATION; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; LYMPHOCYTIC INFILTRATION; PARAKERATOSIS; PRIORITY JOURNAL; PURPURA; SKIN BIOPSY;

EID: 0037709398     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.574     Document Type: Letter

References (6)

1. Hercogova J. Persistent pigmented purpuric dermatoses: who are you? J Eur Acad Dermatol Venereol 2001;15:15.
2. Solomon AR Jr. The histologic spectrum of the reactive inflammatory vascular dermatoses. Dermatol Clin 1985;3:171-83.
3. Burgdorf W. Cutaneous manifestations of Crohn's disease. J Am Acad Dermatol 1981;5:689-95.
4. Nishioka K, Katayama I, Masuzawa M, Yokozeki H, Nishiyama S. Drug-induced chronic pigmented purpura. J Dermatol 1989;16: 220-2.
5. Vergara G, Silvestre JF, Betlloch I, Vela P, Albares MP, Pascual JC. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002;138:1258-9.
6. Reinhold U, Seiter S, Ugurel S, Tilgen W. Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. J Am Acad Dermatol 1999;41:207-8.